Exclusive access to the eMed GLP-1 Program
eMed is proud to offer Disney a behind-the-scenes look at the GLP-1 Program. FDA-approved, branded medications inside a structured program guided by licensed clinicians.
Access code VIPACCESS

PROVEN OUTCOMES
Industry leading adherence. Real results. Measured from day one.
GLP-1 program adherence rate
Reduction in prediabetes risk
Among members with HbA1C > 5.7% at enrollment
Average weight lost per member
Starting average: 215 lbs
eMed is proud to offer Disney VIPs
Exclusive pricing on GLP-1 medications
eMed Program Access
Your program membership is covered. If you qualify for medication, exclusive pricing is available below.
Access code VIPACCESS

You’ve got GLP-1 coverage challenges. eMed has solutions.
Our program takes on the biggest challenges in GLP-1 coverage: inflated pricing, access barriers, low adherence, and poor outcomes.
Lower Cost
Reduce clinical cost of care and get direct pricing on FDA-approved medications with no PBM markups, no rebate inflation and no surprises.
More Control
You set the employee contribution. You manage utilization. You own the outcome.
High Adherence
At-home diagnostics, 24/7 support and ongoing progress tracking keeps members coming back.
Guaranteed Outcomes
We guarantee employee weight loss and adherence. If we miss, you pay less.
01
Start Your Journey
Member enrolls via eMed app and receives a screening kit

02
Guided Medical Intake
A complete, clinician-guided intake — all from home.

03
Clinical Review & Delivery
Interactive clinical evaluation & results

04
Weekly Check-Ins
Helping users stay on track — every week, every step.

05
Seamless Monthly Refill Process
Users can manage their refill timing or consult FAQs.

06
Continuous Progress Monitoring
A running summary of health status and improvements — all in one place.

Special pricing for GLP-1 Medication






*Offer valid for the first 2 months (new patients only) through June 30, 2026, then $349/month


*4 mg offer valid through August 31, 2026, then $199/month
Prices reflect self-pay pricing for eligible eMed members. Prescription required. Pricing and availability subject to change. Eligibility restrictions may apply.
For complete safety and efficacy information, please review the Full Prescribing Information for each product:
Wegovy® Prescribing Information and Medication Guide
Zepbound® Prescribing Information and Medication Guide
Wegovy and Zepbound may cause serious side effects, including:
•Possible thyroid tumors, including cancer. Tell your healthcare provider if you get a lump or swelling in your neck, hoarseness, trouble swallowing, or shortness of breath. These may be symptoms of thyroid cancer. In studies with rats, Wegovy, Zepbound, and medicines that work like them caused thyroid tumors, including thyroid cancer. It is not known if Wegovy or Zepbound will cause thyroid tumors, or a type of thyroid cancer called medullary thyroid carcinoma (MTC) in people.
•Do not use Wegovy or Zepbound if you or any of your family have ever had a type of thyroid cancer called medullary thryoid carcinoma (MTC), or if you have an endocrine system condition called Multiple Endocrine Neoplasia syndrome type 2 (MEN 2).
See Indication and Important Safety Information here.
Access the eMed GLP-1 Program
Your journey begins here.



